Daniel M. Junius - 17 Nov 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: Director
Issuer ticker: GLYC
Reported as of: 17 Nov 2022
Net transaction value: +$37,400
SEC form: 4
Accepted by SEC: 18 Nov 2022, 15:01:46 UTC
Prior SEC filing: 01 Nov 2022
Next SEC filing: 07 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, attorney-in-fact

Key filing fact

Daniel M. Junius filed Form 4 for GLYCOMIMETICS INC (GLYC) on 18 Nov 2022.

Key facts

This page summarizes Daniel M. Junius's Form 4 filing for GLYCOMIMETICS INC (GLYC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Nov 2022, 15:01.

Change

Previous filing in this sequence was filed on 01 Nov 2022.
Current net transaction value: +$37,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Purchase

Transaction value: $37,400
Shares: +20,000
Change %: +46%
Price: $1.87
Shares after: 63,250
Date: 17 Nov 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.855 to $1.89 per share, with a weighted average purchase price of $1.87 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.